MICHELLE A FANALE to Tumor Lysis Syndrome
This is a "connection" page, showing publications MICHELLE A FANALE has written about Tumor Lysis Syndrome.
Connection Strength
0.096
-
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome. Ann Oncol. 2012 Jun; 23(6):1640-5.
Score: 0.096
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.